Mark Hensley's most recent trade in Heron Therapeutics Inc was a trade of 500,000 Restricted Stock Units done . Disclosure was reported to the exchange on May 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Heron Therapeutics Inc | Mark Hensley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 500,000 | 500,000 | - | - | Restricted Stock Units |